Vicky Rhodes is a pharmacist who is specialized in Oncology in Vancouver, Washington. Patients can reach her at 400 Ne Mother Joseph Pl, Vancouver or contact her on 360-514-2061. Active license number of Vicky Rhodes is 10150 for Oncology in Washington. Vicky Rhodes is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Vicky Rhodes speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Vicky Rhodes
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
400 Ne Mother Joseph Pl, Vancouver, Washington, 98664-3200
Phone:
360-514-2061
Fax:
360-514-2570
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Vicky Rhodes are as mentioned below.
NPI Number:
1629269063
NPI Enumeration Date:
08 Aug, 2007
NPI Last Update On:
08 Aug, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Vicky Rhodes are as mentioned below.
Specialization
License Number
State
Status
Oncology
10150
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
400 Ne Mother Joseph Pl, Vancouver, Washington
Zip:
98664-3200
Phone Number:
360-514-2061
Fax Number:
360-514-2570
Patients can reach Vicky Rhodes at 400 Ne Mother Joseph Pl, Vancouver, Washington or can call on phone at 360-514-2061.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.